A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

According to Nova One Advisor, the global gene editing market size is calculated at USD 11.29 billion in 2025 and is expected ...

Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...

A hospitalized patient triggers a major setback for Intellia's $1.9B flagship drug, shaking investor faith overnight ...

In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...

Most current approaches rely on adding nuclear localization signal (NLS) motifs to the ends of Cas9 to facilitate nuclear entry. However, this method is inefficient, and much of the Cas9 that is ...

The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the ...

The news for the chocolate industry is a welcome development, as businesses and scientists grapple with crop shortages.

Chocolate prices have been rising due to complications in the supply chain, but Penn State researchers have made a ...

CRISPR-Cas9 gene editing holds immense potential in the field of precision medicine for liver diseases. This innovative technology permits researchers to precisely modify genes linked to liver ...

A researcher at the University of Houston finds management of diabetic ketoacidosis may center around reducing ketone levels ...